Related Experiment Video
Updated: Apr 4, 2026
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
Molecular heterogeneity in adjacent cells in triple-negative breast cancer
Michael L Huebschman1, Nancy L Lane1, Huaying Liu1
1Harold C Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.
Purpose:
This study interrogates the molecular status of individual cells in patients with triple-negative breast cancers and explores the molecular identification and characterization of these tumors to consider the exploitation of a potential-targeted therapeutic approach.
Patients And Methods:
Hyperspectral immunologic cell by cell analysis was applied to touch imprint smears obtained from fresh tumors of breast cancer patients.
Results:
Cell by cell analysis confirms significant intratumoral molecular heterogeneity in cancer markers with differences from polymerase chain reaction marker reporting. The individual cell heterogeneity was recognized in adjacent cells examined with panels of ten molecular markers in each single cell and included some markers that are considered to express "stem-cell" character. In addition, heterogeneity did not relate either to the size or stage of the primary tumor or to the site from within the cancer.
Conclusion:
There is a very significant molecular heterogeneity when "adjacent cells" are examined in triple-negative breast cancer, thereby making a successful targeted approach unlikely. In addition, it is not reasonable to consider that these changes will provide an answer to tumor dormancy.
Insights
Triple-negative breast cancer exhibits significant molecular heterogeneity at the individual cell level, challenging the effectiveness of targeted therapies. This cellular diversity may not explain tumor dormancy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Triple-negative breast cancer (TNBC) lacks targeted therapies due to its heterogeneity.
- Understanding TNBC's molecular landscape is crucial for treatment development.
Purpose of the Study:
- To investigate the molecular status of individual cells in TNBC patients.
- To characterize tumor molecular profiles for potential targeted therapeutic strategies.
Main Methods:
- Hyperspectral immunologic cell-by-cell analysis was performed on touch imprint smears from fresh TNBC tumors.
- Panels of ten molecular markers, including stem-cell markers, were analyzed in individual cells.
Main Results:
- Significant intratumoral molecular heterogeneity was confirmed at the single-cell level.
- Heterogeneity was observed in adjacent cells and did not correlate with tumor size, stage, or location.
- Individual cell analysis revealed differences compared to polymerase chain reaction marker reporting.
Conclusions:
- High molecular heterogeneity in adjacent TNBC cells makes targeted approaches unlikely to succeed.
- This heterogeneity is unlikely to explain tumor dormancy mechanisms.
